Cargando…
Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
Multiple sclerosis (MS) is the most common autoimmune and demyelinating disease of the central nervous system (CNS), characterized, in the majority of cases, by initial relapses that later evolve into progressive neurodegeneration, severely impacting patients’ motor and cognitive functions. Despite...
Autores principales: | Pinto, Maria V., Fernandes, Adelaide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504120/ https://www.ncbi.nlm.nih.gov/pubmed/32825077 http://dx.doi.org/10.3390/ijms21175960 |
Ejemplares similares
-
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
por: Nizami, Sohaib, et al.
Publicado: (2019) -
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
por: Lepiarz-Raba, Izabela, et al.
Publicado: (2023) -
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
por: Janda, Elzbieta, et al.
Publicado: (2018) -
Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis
por: Nheu, Danica, et al.
Publicado: (2022) -
Reticulocalbin-1 Facilitates Microglial Phagocytosis
por: Ding, Ying, et al.
Publicado: (2015)